Chen Jeffrey W, Augustinus Simone A, Bonsing Bert A, Bouwense Stefan A W, De Hingh Ignace H J T, Van Eijck Casper H, Groot Koerkamp Bas, Hendriks Tessa E, Engelsman Anton F, Besselink Marc G, Nieveen van Dijkum Els J M
Amsterdam UMC, Location University of Amsterdam, Department of Surgery, Amsterdam, the Netherlands; Cancer Center Amsterdam, Amsterdam, the Netherlands; Amsterdam Center for Endocrine and Neuroendocrine Tumors (ACcENT), Amsterdam, the Netherlands.
Amsterdam UMC, Location University of Amsterdam, Department of Surgery, Amsterdam, the Netherlands; Cancer Center Amsterdam, Amsterdam, the Netherlands.
HPB (Oxford). 2025 Apr;27(4):562-571. doi: 10.1016/j.hpb.2024.12.024. Epub 2025 Jan 7.
Pancreatic resections for pancreatic neuroendocrine tumors (pNET) may experience a higher complication rate than for pancreatic ductal adenocarcinoma (PDAC). This study aimed to determine the rate of the novel composite "Ideal Outcome" measure after resection for pNET, using PDAC as reference.
This observational cohort study included all consecutive patients after pancreatic resection for pNET and PDAC using the nationwide Dutch Pancreatic Cancer Audit (2014-2021). The primary outcome was Ideal Outcome; absence of postoperative mortality, postoperative pancreatic fistulas (POPF) grade B/C, other major complications, prolonged length of stay, reoperations and readmissions.
In total, 524 pNET and 2851 PDAC resections were included. The rate of Ideal Outcome was lower after resection for pNET (47.7% versus 55.7%; P<0.001) as compared to PDAC. This difference was driven by a lower rate of Ideal Outcome after pancreatoduodenectomy for pNET (37.7% versus 56.3%; P<0.001), with no difference after left pancreatectomy (54.5% versus 52.5%; P=0.598). Among the individual components of Ideal Outcome after pancreatoduodenectomy, the largest difference was a four times higher rate of POPF (32.1% versus 7.9%; P<0.001) after resection of pNET.
Patients undergoing pancreatoduodenectomy for pNET have a reduced Ideal Outcome rate compared to patients with PDAC, related to a fourfold increased risk of POPF. This highlights the value of pNET-specific patient counseling and the need for effective POPF mitigation strategies.
胰腺神经内分泌肿瘤(pNET)的胰腺切除术并发症发生率可能高于胰腺导管腺癌(PDAC)。本研究旨在以PDAC作为对照,确定pNET切除术后新的复合“理想结局”指标的发生率。
这项观察性队列研究纳入了使用荷兰全国性胰腺癌审计(2014 - 2021年)进行pNET和PDAC胰腺切除术后的所有连续患者。主要结局是理想结局;无术后死亡、B/C级术后胰瘘(POPF)、其他主要并发症、住院时间延长、再次手术和再次入院。
总共纳入了524例pNET切除术和2851例PDAC切除术。与PDAC相比,pNET切除术后理想结局的发生率较低(47.7%对55.7%;P<0.001)。这种差异是由于pNET胰十二指肠切除术后理想结局的发生率较低(37.7%对56.3%;P<0.001),而左半胰切除术后无差异(54.5%对52.5%;P = 0.598)。在胰十二指肠切除术后理想结局的各个组成部分中,最大的差异是pNET切除术后POPF的发生率高出四倍(32.1%对7.9%;P<0.001)。
与PDAC患者相比,接受pNET胰十二指肠切除术的患者理想结局发生率降低,这与POPF风险增加四倍有关。这突出了针对pNET患者进行个性化咨询的价值以及有效减轻POPF策略的必要性。